Brendan Hannah, Chief Business Officer and COO: Quince Therapeutics QNCX Buy · Filed 24/08/21

Trade details

Type: Insider buy
Amount: $1,390.8
Shares · price: 2,280 sh · $0.61 a share
Held after: 267,975 sh
Stock: Quince Therapeutics QNCX
Person: Brendan HannahChief Business Officer and COO
Trade date: 24/08/21
Filed: 24/08/21
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +0.9%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/22~24/09/20

Brendan Hannah's recent trades

Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$14.8K
23,565 sh
$14.8K
Filed 24/08/21
Traded 24/08/21
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$2,054
3,424 sh
$2,054
Filed 24/08/21
Traded 24/08/20
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$3,100
5,000 sh
$3,100
Filed 24/08/21
Traded 24/08/21
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$1,250
2,155 sh
$1,250
Filed 24/08/21
Traded 24/08/19
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$1,525
2,500 sh
$1,525
Filed 24/08/21
Traded 24/08/20

Brendan Hannah, COO — bought $1,391 of Quince Therapeutics QNCX · 2,280 sh @ $0.61 | Whalegun